There have been 50 recent insider transactions recorded for Revolution Medicines, Inc. (RVMD), including 7 buys and 39 sells. Total insider buying was valued at $37.72M and total insider selling at $12.93M.
Notable insiders with recent activity include Mancini Anthony, Sandler Alan B., Cislini Jeff. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — RVMD
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-25 |
Mancini Anthony |
See Remarks |
Informative Sell |
400 |
$97.21 |
$38.88K |
54,400 |
| 2026-03-20 |
Sandler Alan B. |
Chief Development Officer |
Unknown |
11,700 |
$102.02 |
$1.19M |
- |
| 2026-03-20 |
Mancini Anthony |
See Remarks |
Unknown |
26,200 |
$102.02 |
$2.67M |
- |
| 2026-03-19 |
Cislini Jeff |
General Counsel |
Informative Sell |
1,163 |
$97.44 |
$113.32K |
58,518 |
| 2026-03-17 |
Goldsmith Mark A |
See Remarks |
Informative Sell |
12,871 |
$99.48 |
$1.28M |
276,698 |
| 2026-03-17 |
Horn Margaret A |
Chief Operating Officer |
Informative Sell |
4,583 |
$99.48 |
$455.92K |
157,570 |
| 2026-03-17 |
Kelsey Stephen Michael |
See Remarks |
Informative Sell |
4,302 |
$99.48 |
$427.96K |
295,398 |
| 2026-03-17 |
Anders Jack |
Chief Financial Officer |
Informative Sell |
2,753 |
$99.48 |
$273.87K |
125,512 |
| 2026-03-17 |
Wang Xiaolin |
See Remarks |
Informative Sell |
2,010 |
$99.48 |
$199.96K |
116,063 |
| 2026-03-17 |
Wei Lin |
Chief Medical Officer |
Informative Sell |
2,073 |
$99.48 |
$206.22K |
101,366 |
| 2026-03-17 |
Cislini Jeff |
General Counsel |
Informative Sell |
1,795 |
$99.48 |
$178.57K |
59,681 |
| 2026-03-04 |
Anderson Elizabeth M |
Director |
Gift (Given) |
15,000 |
- |
- |
8,215 |
| 2026-03-02 |
Goldsmith Mark A |
See Remarks |
Option Exercise (Sell) |
30,000 |
$4.09 |
$122.7K |
47,708 |
| 2026-03-01 |
Goldsmith Mark A |
See Remarks |
RSU Award |
128,600 |
$102.02 |
$13.12M |
128,600 |
| 2026-03-01 |
Horn Margaret A |
Chief Operating Officer |
RSU Award |
47,600 |
$102.02 |
$4.86M |
47,600 |
| 2026-03-01 |
Kelsey Stephen Michael |
See Remarks |
RSU Award |
47,600 |
$102.02 |
$4.86M |
47,600 |
| 2026-03-01 |
Anders Jack |
Chief Financial Officer |
RSU Award |
45,400 |
$102.02 |
$4.63M |
45,400 |
| 2026-03-01 |
Wang Xiaolin |
See Remarks |
RSU Award |
34,000 |
$102.02 |
$3.47M |
34,000 |
| 2026-03-01 |
Wei Lin |
Chief Medical Officer |
RSU Award |
34,000 |
$102.02 |
$3.47M |
34,000 |
| 2026-03-01 |
Cislini Jeff |
General Counsel |
RSU Award |
32,500 |
$102.02 |
$3.32M |
32,500 |
| 2026-02-06 |
Goldsmith Mark A |
See Remarks |
Option Exercise (Sell) |
24,010 |
$0.54 |
$12.97K |
144,493 |
| 2026-01-21 |
Cislini Jeff |
General Counsel |
Informative Sell |
908 |
$115.60 |
$104.96K |
46,976 |
| 2026-01-07 |
Horn Margaret A |
Chief Operating Officer |
Option Exercise (Sell) |
51,406 |
$42.45 |
$2.18M |
1,094 |
| 2026-01-07 |
Anders Jack |
Chief Financial Officer |
Option Exercise (Sell) |
10,000 |
$42.45 |
$424.5K |
15,900 |
| 2025-12-16 |
Goldsmith Mark A |
See Remarks |
Informative Sell |
15,394 |
$76.82 |
$1.18M |
232,469 |
| 2025-12-16 |
Horn Margaret A |
Chief Operating Officer |
Informative Sell |
4,847 |
$76.82 |
$372.33K |
141,053 |
| 2025-12-16 |
Kelsey Stephen Michael |
See Remarks |
Informative Sell |
5,447 |
$76.82 |
$418.42K |
278,600 |
| 2025-12-16 |
Anders Jack |
Chief Financial Officer |
Informative Sell |
3,104 |
$77.09 |
$239.29K |
108,065 |
| 2025-12-16 |
Cislini Jeff |
General Counsel |
Informative Sell |
2,688 |
$76.82 |
$206.48K |
47,884 |
| 2025-11-25 |
Goldsmith Mark A |
See Remarks |
Informative Sell |
3,000 |
$75.00 |
$225K |
67,424 |
| 2025-11-25 |
Anders Jack |
Chief Financial Officer |
Option Exercise (Sell) |
5,418 |
$17.00 |
$92.11K |
- |
| 2025-11-18 |
Goldsmith Mark A |
See Remarks |
Option Exercise (Sell) |
20,000 |
$4.09 |
$81.8K |
137,708 |
| 2025-11-18 |
Cislini Jeff |
General Counsel |
Option Exercise (Sell) |
13,388 |
$42.45 |
$568.32K |
- |
| 2025-11-12 |
Goldsmith Mark A |
See Remarks |
Gift (Received) |
50,000 |
- |
- |
54,498 |
| 2025-11-12 |
Goldsmith Mark A |
See Remarks |
Option Exercise (Sell) |
20,000 |
$4.09 |
$81.8K |
157,708 |
| 2025-11-11 |
Anders Jack |
Chief Financial Officer |
Option Exercise (Sell) |
10,000 |
$17.00 |
$170K |
5,418 |
| 2025-11-07 |
Goldsmith Mark A |
See Remarks |
Option Exercise (Sell) |
26,479 |
$1.12 |
$29.66K |
- |
| 2025-10-13 |
Kelsey Stephen Michael |
See Remarks |
Informative Sell |
25,000 |
$48.54 |
$1.21M |
284,047 |
| 2025-06-20 |
Cislini Jeff |
General Counsel |
Informative Sell |
1,912 |
$39.61 |
$75.74K |
54,093 |
| 2025-06-16 |
Goldsmith Mark A |
See Remarks |
Informative Sell |
13,496 |
$39.83 |
$537.55K |
428,720 |
| 2025-06-16 |
Horn Margaret A |
Chief Operating Officer |
Informative Sell |
3,510 |
$39.83 |
$139.8K |
150,675 |
| 2025-06-16 |
Kelsey Stephen Michael |
See Remarks |
Informative Sell |
4,289 |
$39.83 |
$170.83K |
289,414 |
| 2025-06-16 |
Anders Jack |
Chief Financial Officer |
Informative Sell |
2,170 |
$39.83 |
$86.43K |
113,314 |
| 2025-06-16 |
Wei Lin |
Chief Medical Officer |
Informative Sell |
2,173 |
$39.83 |
$86.55K |
90,499 |
| 2025-06-16 |
Cislini Jeff |
General Counsel |
Informative Sell |
1,878 |
$39.83 |
$74.8K |
56,005 |
| 2025-03-20 |
Cislini Jeff |
General Counsel |
Informative Sell |
2,041 |
$38.71 |
$79.01K |
57,723 |
| 2025-03-17 |
Goldsmith Mark A |
See Remarks |
Informative Sell |
11,738 |
$39.04 |
$458.26K |
441,564 |
| 2025-03-17 |
Horn Margaret A |
Chief Operating Officer |
Informative Sell |
3,058 |
$39.04 |
$119.39K |
153,533 |
| 2025-03-17 |
Kelsey Stephen Michael |
See Remarks |
Informative Sell |
3,294 |
$39.04 |
$128.6K |
293,051 |
| 2025-03-17 |
Anders Jack |
Chief Financial Officer |
Informative Sell |
1,864 |
$39.04 |
$72.77K |
115,006 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry